website main logo


The AI revolution is well underway. Yet our industry has only scratched the surface of how it will transform the discovery and development of life-changing medicines. BeyondBio AI is working towards that future, creating an unparalleled space for innovation to thrive.

From building new AI ventures to championing existing platforms, we connect Israel’s best solutions to pharma’s most pressing R&D challenges. At the heart: matching bold entrepreneurs, scientists, and technologists with deep industry knowledge, scientific expertise, and data.

The result? Fast-tracked progress that makes a crucial difference in startups’ success. 


In this pioneering lab, new Israeli startups are tailor-made to address pharma’s most urgent problems with precision. A key initiative of BeyondBio AI, AION Labs was born of a groundbreaking alliance of AstraZeneca, Merck, Pfizer, and Teva, along with AWS and the Israel Biotech Fund, supported by the Israeli Innovation Authority.

If you’re a scientist, technologist or entrepreneur looking to establish your startup with deep support from across the industry, we welcome you to get in touch.


This track is tailored to exciting, evidence-based AI platforms, selected for direct collaboration with AstraZeneca’s R&D teams. Working together, we steer innovation with rare precision and speed: from matching a solution to a viable problem, to refining its value proposition, validation, and deployment through a range of collaboration models. 

We’re always looking for groundbreaking solutions. Get in touch if you have an AI platform geared at transforming the R&D journey, from the early drug discovery phase up to clinical trial success. Let’s explore how we can work together to unlock your startup’s full potential.